UTHR UNITED THERAPEUTICS Corp
Price Chart
Executive Summary
Three top executives at United Therapeutics (CEO, CFO, General Counsel) collectively sold $1.11M in open-market shares over a 5-day window, all following derivative exercises at deep in-the-money strike prices. The sales are consistent with routine post-vesting tax and diversification activity — the total represents ~0.005% of the $23.3B market cap, well below the materiality threshold for informational selling. The cluster is amplified by the cross-filing context (cluster-insider-trades + cluster-earnings-context), but the absolute dollar value is trivial for a company of this size.
Key Financial Metrics
Actionable Insight
This cluster is routine post-vesting selling by top executives — the dollar amounts are negligible for a $23B company. The simultaneous option exercises suggest a scheduled vesting event rather than a coordinated bearish signal. No actionable trading signal here; monitor the next 10-Q for any fundamental changes.
Key Facts
- CEO Martine Rothblatt sold 2,926 shares total across 3 days for ~$1.58M, all after exercising options at $146.03
- CFO James Edgemond sold 1,440 shares for ~$785K after exercising options at $117.76
- General Counsel Paul Mahon sold 200 shares for ~$108K after exercising options at $146.03
- Total open-market sales: $1.11M, representing ~0.005% of UTHR's $23.3B market cap
- All three insiders simultaneously exercised options — a pattern consistent with scheduled vesting/expiration, not coordinated bearish conviction
- Historical performance on UTHR reports shows a 17% win rate at T+20 with avg alpha of -6.51%, suggesting the model has over-scored this ticker
Financial Impact
Total insider sales of $1.11M are immaterial relative to $23.3B market cap (0.005%)
Risk Factors
- Insider selling at the C-suite level, even if routine, can weigh on sentiment if the stock is at all-time highs
- The historical calibration shows UTHR reports have underperformed at T+20, suggesting the stock may face headwinds regardless of this filing
Market Snapshot
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-UTHR-1780608665703 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 10, 2026
4d ago
|
Insider Cluster
| $544.59 awaiting T+1 | awaiting T+1 | — | $545.96 (+0.25%) |
|
Jun 9, 2026
5d ago
|
Insider Cluster
| $553.04 awaiting T+1 | awaiting T+1 | — | $545.96 (−1.28%) |
|
Jun 5, 2026
9d ago
|
Insider Cluster
| $547.10 awaiting T+1 | awaiting T+1 | — | $545.96 (−0.21%) |
|
Jun 4, 2026
10d ago
|
Insider Cluster
| $547.10 awaiting T+1 | awaiting T+1 | — | $545.96 (−0.21%) |
|
Jun 4, 2026
10d ago
|
Insider Cluster
| $547.10 awaiting T+1 | awaiting T+1 | — | $545.96 (−0.21%) |
|
Jun 3, 2026
11d ago
|
Insider Cluster
| $547.22 $546.37 | ▼ −0.16% | ▲ +2.44% | $545.96 (−0.23%) |
|
May 29, 2026
16d ago
|
Insider Cluster
| $544.45 $539.91 | ▼ −0.83% | ▼ −0.98% | $545.96 (+0.28%) |
|
May 28, 2026
17d ago
|
Insider Cluster
| $553.34 $544.45 | ▼ −1.61% | ▼ −1.86% | $545.96 (−1.33%) |
|
May 27, 2026
18d ago
|
Insider Cluster
| $561.70 $553.34 | ▼ −1.49% | ▼ −1.73% | $545.96 (−2.80%) |
|
May 26, 2026
19d ago
|
Insider Cluster
| $567.74 $561.70 | ▼ −1.06% | ▼ −1.62% | $545.96 (−3.84%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access